Rie Hantani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

SLAS discovery : advancing life sciences R & D

Chemical biology & drug design

Japan Tobacco (Japan)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Japan Tobacco (Japan) Oct 01 1999

Japan

Senior Research Scientist :: Central Pharmaceutical Research Institute

Publications

Kazuki Otake, Yoshinori Hara, Minoru Ubukata, Masafumi Inoue, Noboru Nagahashi, Dai Motoda, Naoki Ogawa, Yoshiji Hantani, Rie Hantani, Tsuyoshi Adachi, Akihiro Nomura, Keishi Yamaguchi, Mariko Maekawa, Hideaki Mamada, Takahisa Motomura, Motohide Sato, Kazuhito Harada
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry 67 (5) (2024)
Kazuki Otake, Yoshinori Hara, Minoru Ubukata, Masafumi Inoue, Noboru Nagahashi, Dai Motoda, Naoki Ogawa, Yoshiji Hantani, Rie Hantani, Tsuyoshi Adachi, Akihiro Nomura, Keishi Yamaguchi, Mariko Maekawa, Hideaki Mamada, Takahisa Motomura, Motohide Sato, Kazuhito Harada
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry 67 (5) (2024)
Kazuki Otake, Yoshinori Hara, Minoru Ubukata, Masafumi Inoue, Noboru Nagahashi, Dai Motoda, Naoki Ogawa, Yoshiji Hantani, Rie Hantani, Tsuyoshi Adachi, Akihiro Nomura, Keishi Yamaguchi, Mariko Maekawa, Hideaki Mamada, Takahisa Motomura, Motohide Sato, Kazuhito Harada
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry (2024)
Kazuki Otake, Yoshinori Hara, Minoru Ubukata, Masafumi Inoue, Noboru Nagahashi, Dai Motoda, Naoki Ogawa, Yoshiji Hantani, Rie Hantani, Tsuyoshi Adachi, Akihiro Nomura, Keishi Yamaguchi, Mariko Maekawa, Hideaki Mamada, Takahisa Motomura, Motohide Sato, Kazuhito Harada
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry 67 (5) (2024)
Seiji Kawashita, Koichi Aoyagi, Kyoko Fukushima, Rie Hantani, Shiori Naruoka, Atsuo Tanimoto, Yuji Hori, Yukiyo Toyonaga, Hiroshi Yamanaka, Susumu Miyazaki, Yoshiji Hantani
SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction. Chemical biology & drug design 98 (5) (2021)
Rie Hantani, Saya Hanawa, Shohei Oie, Kayo Umetani, Toshihiro Sato, Yoshiji Hantani
Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation. SLAS discovery : advancing life sciences R & D 24 (8) (2019)

Rie Hantani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rie Hantani